Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease

Journal of Clinical Pathology

Volumn 49, Issue 1, 1996, Pages 65-67

  Halme, L ^a   Rautclin, H ^b   Leidenius, M ^a   Kosunen, T U ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Crohn's disease; Helicobacter pylori; IgA; IgG; Seroprevalence; Ulcerative colitis

Indexed keywords

BACTERIUM ANTIBODY; CIPROFLOXACIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; METRONIDAZOLE; OFLOXACIN; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME IMMUNOASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0030025008     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.1.65     Document Type: Article

References (17)

1. Sanderson JD, Moss MT, Tizard ML, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992;33:890-6.
2. Ibbotson JP, Lowes JR, Chahal M, Gaston JSH, Life P, Kumararatne DS, et al. Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease. Clin Exp Immunol 1992;87:224-230.
3. Giaffer MH, Holdworth CD, Duerden BI. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut 1992;33:646-50.
4. Ekhom A, Wakefield AJ, Zack M, Adarni HO. Perinatal measles infection and subsequent Crohn's disease. Lancet 1994;344:508-10.
5. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
6. El-Omar E, Penman I, Cruikshank G, Dover S, Banerjee S, Williams C, et al. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 1994;35:1385-8.
7. Halme L, Kärkkäinen P, Rautelin H, Kosunen TU, Sipponen P. High frequency of helicobacter negative gastritis in patients with Crohn's disease. Gut 1996 (in press).
8. Kosunen TU, Höök J, Rautelin H, Myllylä G. Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol 1989;24:110-14.
9. Kosunen TU, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339: 893-5.
10. Taha AS, Sturrock RD, Russell RI. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulphasalazine and non-steroidal anti-inflammatory drugs. Am J Gastroenterol 1992;87:1732-5.
11. Eastwood GL. Epithelial renewal in protection and repair of gastroduodenal mucosa. J Clin Gastroenterol 1991;13 (Suppl 1):48-53.
12. Sorensen VZ, Olsen BG, Binder V. Life prospects and quality of life in patients with Crohn's disease. Gut 1987; 28: 382-5.
13. Hopkins RJ, Vial PA, Ferreccio C, Ovalle J, Prado P, Sotomayor V, et al. Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as a route of transmission. J Infect Dis 1993;168:222-6.
14. Banatvala N, Mayo K, Megraud H, Jennings R, Decks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21.
15. Kuipers EJ, Pena AS, van Kamp G, Uyterlinde AM, Pals G, Pels NF, et al. Seroconversion for Helicobacter pylori. Lancet 1993;342:238-41.
16. Mitchell HM, Li YY, Hu PJ, Liu Q, Chen M, Du GG, et al. Epidemiology of Helicobacter pylori in Southern China: Identification of early childhood as the critical period of acquisition. J Infect Dis 1992;166:149-53.
17. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339:896-7.